Altered Hemodynamics and Hyperuricemia Accompany an Elevated sFlt-1/PlGF Ratio Before the Onset of Early Severe Preeclampsia

Sibai, 1995, Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, Am J Obstet Gynecol, 172, 642, 10.1016/0002-9378(95)90586-3 Hypertension in pregnancy, 2013, Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy, Obstet Gynecol, 122, 1122 Kucukgoz, 2013, Comparison of clinical and laboratory findings in early- and late-onset preeclampsia, J Matern Fetal Neonatal Med, 26, 1228, 10.3109/14767058.2013.776533 Raymond, 2011, A critical review of early-onset and late-onset preeclampsia, Obstet Gynecol Surv, 66, 497, 10.1097/OGX.0b013e3182331028 Valensise, 2008, Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease, Hypertension, 52, 873, 10.1161/HYPERTENSIONAHA.108.117358 Walker, 2012, Sex-specific basis of severe placental dysfunction leading to extreme preterm delivery, Placenta, 33, 568, 10.1016/j.placenta.2012.03.011 Vasapollo, 2008, Total vascular resistance and left ventricular morphology as screening tools for complications in pregnancy, Hypertension, 51, 1020, 10.1161/HYPERTENSIONAHA.107.105858 Thangaratinam, 2006, Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review, BJOG, 113, 369, 10.1111/j.1471-0528.2006.00908.x Noori, 2010, Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension, Circulation, 122, 478, 10.1161/CIRCULATIONAHA.109.895458 Toal, 2008, Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images, Am J Obstet Gynecol, 198, 330, 10.1016/j.ajog.2007.09.031 Proctor, 2009, Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A, Ultrasound Obstet Gynecol, 34, 274, 10.1002/uog.7308 Porat, 2013, Placental hyperinflation and the risk of adverse perinatal outcome, Ultrasound Obstet Gynecol, 42, 315, 10.1002/uog.12386 Squara, 2007, Noninvasive cardiac output monitoring (NICOM): a clinical validation, Intensive Care Med, 33, 1191, 10.1007/s00134-007-0640-0 Raval, 2008, Multicenter evaluation of noninvasive cardiac output measurement by bioreactance technique, J Clin Monit Comput, 22, 113, 10.1007/s10877-008-9112-5 American College of Obstetricians and Gynaecologists, 2002, Diagnosis and management of preeclampsia and eclampsia. ACOG practice bulletin, no. 33, January 2002, Obstet Gynecol, 99, 159, 10.1097/00006250-200201000-00028 Ray, 2012, Birth weight curves tailored to maternal world region, J Obstet Gynaecol Can, 34, 159, 10.1016/S1701-2163(16)35159-3 North, 2011, Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort, BMJ, 342, d1875, 10.1136/bmj.d1875 Bamfo, 2006, Maternal cardiac function in fetal growth restriction, BJOG, 113, 784, 10.1111/j.1471-0528.2006.00945.x Easterling, 1999, Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension, Obstet Gynecol, 93, 725 Dennis, 2010, Prospective observational study of serial cardiac output by transthoracic echocardiography in healthy pregnant women undergoing elective caesarean delivery, Int J Obstet Anesth, 19, 142, 10.1016/j.ijoa.2009.06.007 Khaw, 2008, Maternal cardiac function and uterine artery Doppler at 11–14 weeks in the prediction of pre-eclampsia in nulliparous women, BJOG, 115, 369, 10.1111/j.1471-0528.2007.01577.x Bamfo, 2008, Maternal cardiac function in normotensive and pre-eclamptic intrauterine growth restriction, Ultrasound Obstet Gynecol, 32, 682, 10.1002/uog.5311 Melchiorre, 2012, Maternal cardiovascular impairment in pregnancies complicated by severe fetal growth restriction, Hypertension, 60, 437, 10.1161/HYPERTENSIONAHA.112.194159 Melchiorre, 2011, Maternal cardiac function in preeclampsia, Curr Opin Obstet Gynecol, 23, 440, 10.1097/GCO.0b013e32834cb7a4 Rana, 2012, Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia, Circulation, 125, 911, 10.1161/CIRCULATIONAHA.111.054361 Taylor, 2003, Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies, Am J Obstet Gynecol, 188, 177, 10.1067/mob.2003.111 Osol, 2008, Placental growth factor is a potent vasodilator of rat and human resistance arteries, Am J Physiol Heart Circ Physiol, 294, H1381, 10.1152/ajpheart.00922.2007 Levine, 2004, Circulating angiogenic factors and the risk of preeclampsia, N Engl J Med, 350, 672, 10.1056/NEJMoa031884 Bellomo, 2011, Prognostic significance of serum uric acid in women with gestational hypertension, Hypertension, 58, 704, 10.1161/HYPERTENSIONAHA.111.177212 Roberts, 2005, Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension, Hypertension, 46, 1263, 10.1161/01.HYP.0000188703.27002.14